Psychological interventions in patients with lung cancer: A review of the research literature

Cáncer de pulmón; Ansiedad; DepresiónLung cancer; Anxiety; DepressionCàncer de pulmó; Ansietat; DepressióIntroducción. El cáncer de pulmón (CP) es una de las principales causas de mortalidad en México y representa un grave problema de salud pública. Los pacientes reportan diversas afectaciones psicosociales, entre las cuales los síntomas de ansiedad, depresión y estigma percibido son los que más repercuten en su calidad de vida. Se han desarrollado diversas intervenciones psicológicas para ayudar a mejorar el estado psicológico de los pacientes con cáncer; sin embargo, la evidencia es particularmente limitada en los pacientes con CP. Objetivo. Conocer la evidencia acerca de las intervenciones psicológicas para aminorar o eliminar los síntomas de ansiedad, depresión y estigma percibido, y para mejorar por consiguiente su calidad de vida. Método. Se realizó una búsqueda PIOen las bases de datos PubMed, PsycINFO y Cochrane Library, sin restringir las fechas de publicación de los artículos. Resultados. Se obtuvo un total de 653 artículos, considerándose para esta revisión cuatro ensayos controlados aleatorizados y un cuasiexperimento. Discusión. Esta revisión propor-ciona evidencia respecto a la efectividad de diversas intervenciones psicológicas, siendo la terapia cognitivo-conductual el tipo de intervención más reportada y con mayores efectos positivos en la reducción de las variables mencionadas y la mejora de la calidad de vida, por lo que se recomienda llevar a cabo más análisis para demostrar su efectividad en pacientes con CP en población latina, y particularmente en México.Introduction. Lung cancer (LC) is one of the leading causes of mortality in Mexico, representing a serious public health problem. Patients show various psychosocial disorders, among which symptoms of anxiety, depression, and higher levels of perceived stigma are the most prevalent, affecting their quality of life. Various psychological interventions help improve the psychological state of cancer patients; however, the evidence is not as abundant in patients with LC. Objective. To explore the evidence of successful psychological interventions for symptoms of anxiety, depression, perceived stigma, and quality of life in patients with LC. Method. An IOP search was carried out in PubMed, PsycINFO, and Cochrane Library databases. There was no restriction on the publication dates. Results. 653 articles appeared, from which four random control essays and one quasi-experiment were included for this review. Discussion. The results provide evidence regarding the effectiveness of various psychological interventions, behavioral-cognitive therapy is the most frequently reported type of intervention and with the most noticeable positive effects on reducing symptoms of anxiety, depression, and perceived stigma and improving the quality of life. More research would better demonstrate its effectiveness in patients with PC in the Latino population, particularly in Mexico

Ten-year course of treated bipolar I disorder: The role of polarity at onset

Introduction: Early-stage predictors of illness course are needed in bipolar disorder (BD). Differences among patients with a first depressive versus maniac/hypomanic episode have been stated, although in most studies, memory bias and time from onset to start of specialized treatment might interfere. The aim was to compare the first 10 years of illness course according to polarity at onset. Methods: 49 type I BD patients admitted for treatment for a first-time affective episode and a following 10-year attendance to the institution were included. A retrospective year by year comparison according to polarity at onset (depressive (DPO) or maniac (MPO)) was performed. Cramer's V and Cohen d were computed to determine effect size. Results: 59.2% (n = 29) started with MPO. Both groups were similar in demographic and social outcome characteristics, clinical features, and treatment variables. Patients with DPO reported more depressive episodes than MPO patients (U = 149.0 p < .001, Cohen's d = 0.87); both groups had a similar number of manic episodes. Only during the first year of follow-up, suicide attempts (SA) were more frequent in patients with DPO while the presence of a psychotic episode and psychiatric hospitalizations were more frequent in the MPO group. Conclusion: According to these findings, it can be concluded that illness onset is only indicative of depressive predominant polarity but is not related to other poor prognostic variables after the first year of illness onset, in treated BD. SA in the first year of an affective disorder could represent a marker of BD

The role of personality traits on self-medicated cannabis in rheumatoid arthritis patients: a multivariable analysis.

BACKGROUND: Rheumatoid arthritis (RA) patients commonly report medicinal cannabis use (MCU). Personality has been independently associated with both RA-related outcomes and MCU, but there is no information available on how they interact in RA patients. This study aimed to investigate a potential association between personality traits and MCU in RA outpatients, as well as to identify additional factors associated with its use. METHODS: This cross-sectional study was performed between June 2020 and August 2021. Consecutive RA outpatients had standardized evaluations using an interview format to collect sociodemographic information, comorbidities, risk of recreational substance use, RA-related disease activity/severity, health-related quality of life, depressive and anxiety symptoms, five personality traits, and MCU in the 12 months before the interview. Multivariable logistic regression estimated adjusted odds ratios (aOR). The study was IRB-approved. RESULTS: 180 patients were included; 160 (88.9%) were women with a mean age of 53.4 ± 13 years. Fifty-three (29.4%) patients reported MCU. Among them, 52 (98.1%) used topical formulations. Neuroticism had the highest overall score ([Formula: see text] = 3.47 ± 0.34). Openness to experience trait was higher in MCU patients in the comparative analysis (p = 0.007). In the multivariable regression, higher openness trait along with moderate risk in tobacco use and higher RA disease activity/severity were independently associated with MCU. CONCLUSIONS: In the current study, personality influenced the seeking of MCU for pain relief, associating dynamically with higher disease activity/severity and tobacco use. Contrary to other available information, it did not relate to psychopathology or the recreational use of cannabis. Proactive interdisciplinary clinical evaluations around MCU in RA outpatients should include personality, besides standard clinical assessments, to understand patients' motivations for its use as they may reveal important clinical information

The role of personality traits on self-medicated cannabis in rheumatoid arthritis patients: A multivariable analysis.

BackgroundRheumatoid arthritis (RA) patients commonly report medicinal cannabis use (MCU). Personality has been independently associated with both RA-related outcomes and MCU, but there is no information available on how they interact in RA patients. This study aimed to investigate a potential association between personality traits and MCU in RA outpatients, as well as to identify additional factors associated with its use.MethodsThis cross-sectional study was performed between June 2020 and August 2021. Consecutive RA outpatients had standardized evaluations using an interview format to collect sociodemographic information, comorbidities, risk of recreational substance use, RA-related disease activity/severity, health-related quality of life, depressive and anxiety symptoms, five personality traits, and MCU in the 12 months before the interview. Multivariable logistic regression estimated adjusted odds ratios (aOR). The study was IRB-approved.Results180 patients were included; 160 (88.9%) were women with a mean age of 53.4 ± 13 years. Fifty-three (29.4%) patients reported MCU. Among them, 52 (98.1%) used topical formulations. Neuroticism had the highest overall score ([Formula: see text] = 3.47 ± 0.34). Openness to experience trait was higher in MCU patients in the comparative analysis (p = 0.007). In the multivariable regression, higher openness trait (aOR: 2.81, 95%CI: 1.11-7.10) along with moderate risk in tobacco use (aOR: 3.36, 95%CI: 1.04-10.7) and higher RA disease activity/severity (aOR: 1.10, 95%CI: 1.01-1.19) were independently associated with MCU.ConclusionsIn the current study, personality influenced the seeking of MCU for pain relief, associating dynamically with higher disease activity/severity and tobacco use. Contrary to other available information, it did not relate to psychopathology or the recreational use of cannabis. Proactive interdisciplinary clinical evaluations around MCU in RA outpatients should include personality, besides standard clinical assessments, to understand patients' motivations for its use as they may reveal important clinical information

The role of personality traits on self-medicated cannabis in rheumatoid arthritis patients: A multivariable analysis

Background Rheumatoid arthritis (RA) patients commonly report medicinal cannabis use (MCU). Personality has been independently associated with both RA-related outcomes and MCU, but there is no information available on how they interact in RA patients. This study aimed to investigate a potential association between personality traits and MCU in RA outpatients, as well as to identify additional factors associated with its use. Methods This cross-sectional study was performed between June 2020 and August 2021. Consecutive RA outpatients had standardized evaluations using an interview format to collect sociodemographic information, comorbidities, risk of recreational substance use, RA-related disease activity/severity, health-related quality of life, depressive and anxiety symptoms, five personality traits, and MCU in the 12 months before the interview. Multivariable logistic regression estimated adjusted odds ratios (aOR). The study was IRB-approved. Results 180 patients were included; 160 (88.9%) were women with a mean age of 53.4 ± 13 years. Fifty-three (29.4%) patients reported MCU. Among them, 52 (98.1%) used topical formulations. Neuroticism had the highest overall score ( Conclusions In the current study, personality influenced the seeking of MCU for pain relief, associating dynamically with higher disease activity/severity and tobacco use. Contrary to other available information, it did not relate to psychopathology or the recreational use of cannabis. Proactive interdisciplinary clinical evaluations around MCU in RA outpatients should include personality, besides standard clinical assessments, to understand patients’ motivations for its use as they may reveal important clinical information

Additional file 1: of Validity and reliability of a novel Color-Risk Psychiatric Triage in a psychiatric emergency department

Color Risk Psychiatric Triage. Assessment of one from 5 Color-Risk Levels and one from 32 PEP Score. (PDF 80 kb